Seoul, Seoul / / October 9, 2025 / Lydian Cosmetic Surgery Clinic Key Takeaways Stem cell therapy offers a minimally invasive ...

MIT and Harvard scientists have designed an advanced type of immune cell called a CAR-NK cell that can destroy cancer while ...

Johns Hopkins researchers found a way to build lasting tumor-fighting immunity and prevent cancer recurrence by turning ...

Long-term follow-up shows 95% success rate, no serious complications in largest ADA-SCID gene therapy study to date ...

Scientists at University College London have engineered a rare type of immune cell to kill slow-growing bowel cancer cells that are resistant to current therapies, a breakthrough that could lead to ...

In a breakthrough cancer therapy development, scientists at MIT and Harvard Medical School created a new way of designing ...

Multiple sclerosis, which affects around one in 500 people in Switzerland, is an autoimmune disease in which immune cells ...

Scientists discover that loss of MTAP gene disables immune defenses in tumors; DFMO drug could reactivate STING pathway.

New research found that gene therapy for children with "bubble boy disease," or SCID, was successful in 95% of trial ...

Regulatory T cells, which help to dampen inflammation, are being used in clinical trials against ailments such as rheumatoid ...

A one-time gene therapy using a patient’s own stem cells has effectively cured a deadly immune disorder in 95% of treated ...